NO20034412L - Merkaptoacetylamidderivater, fremgangsmåte for deres fremstilling og deresanvendelse - Google Patents

Merkaptoacetylamidderivater, fremgangsmåte for deres fremstilling og deresanvendelse

Info

Publication number
NO20034412L
NO20034412L NO20034412A NO20034412A NO20034412L NO 20034412 L NO20034412 L NO 20034412L NO 20034412 A NO20034412 A NO 20034412A NO 20034412 A NO20034412 A NO 20034412A NO 20034412 L NO20034412 L NO 20034412L
Authority
NO
Norway
Prior art keywords
compounds
preparation
disclosed
mercaptoacetylamide derivatives
mercaptoacetylamide
Prior art date
Application number
NO20034412A
Other languages
English (en)
Other versions
NO325655B1 (no
NO20034412D0 (no
Inventor
Gary A Flynn
Shujaath Mehdi
Jack Roger Koehl
Barbara Ann Anderson
Manfred Gerken
Bernd Jablonka
Heinz-Werner Kleemann
Wolfgang Linz
Werner Seiz
Bernhard Seuring
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0119305.1A external-priority patent/GB0119305D0/en
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20034412L publication Critical patent/NO20034412L/no
Publication of NO20034412D0 publication Critical patent/NO20034412D0/no
Publication of NO325655B1 publication Critical patent/NO325655B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
NO20034412A 2001-04-12 2003-10-02 Merkaptoacetylamidderivater, fremgangsmate for deres fremstilling og deres anvendelse samt farmasoytisk sammensetning og fremgangsmate for fremstilling derav NO325655B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28330501P 2001-04-12 2001-04-12
GBGB0119305.1A GB0119305D0 (en) 2001-04-12 2001-08-08 Mercaptoacetylamide derivatives,a process for their preparation and their use
PCT/EP2002/003668 WO2002083671A1 (en) 2001-04-12 2002-04-03 Mercaptoacetylamide derivatives, a process for their preparation and their use

Publications (3)

Publication Number Publication Date
NO20034412L true NO20034412L (no) 2003-10-02
NO20034412D0 NO20034412D0 (no) 2003-10-02
NO325655B1 NO325655B1 (no) 2008-06-30

Family

ID=26246410

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034412A NO325655B1 (no) 2001-04-12 2003-10-02 Merkaptoacetylamidderivater, fremgangsmate for deres fremstilling og deres anvendelse samt farmasoytisk sammensetning og fremgangsmate for fremstilling derav

Country Status (26)

Country Link
EP (1) EP1381605B1 (no)
JP (1) JP4392167B2 (no)
CN (1) CN1245404C (no)
AT (1) ATE286898T1 (no)
AU (1) AU2002304804B2 (no)
BG (1) BG66387B1 (no)
BR (1) BR0208889A (no)
CA (1) CA2443488C (no)
CZ (1) CZ299708B6 (no)
DE (1) DE60202602T2 (no)
EE (1) EE05272B1 (no)
ES (1) ES2232752T3 (no)
HR (1) HRP20030823B1 (no)
HU (1) HU229612B1 (no)
IL (1) IL158289A0 (no)
MA (1) MA26098A1 (no)
MX (1) MXPA03008613A (no)
NO (1) NO325655B1 (no)
NZ (1) NZ528825A (no)
OA (1) OA12502A (no)
PL (1) PL209338B1 (no)
PT (1) PT1381605E (no)
RU (1) RU2286346C2 (no)
SI (1) SI1381605T1 (no)
SK (1) SK287616B6 (no)
WO (1) WO2002083671A1 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10229180A1 (de) * 2002-06-28 2004-01-29 Aventis Pharma Deutschland Gmbh Verwendung von Vasopeptidase-Inhibitoren bei der Behandlung von metabolischen Erkrankungen, Nephropathie und mit AGE assoziierten Erkrankungen
US8993631B2 (en) 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5430145A (en) * 1990-10-18 1995-07-04 Merrell Dow Pharmaceuticals Inc. Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
CA2053340C (en) * 1990-10-18 2002-04-02 Timothy P. Burkholder Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
EP0534363B1 (en) * 1991-09-27 1997-07-09 Merrell Pharmaceuticals Inc. Novel 2-substituted indane-2-mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace
RU2127261C1 (ru) * 1993-06-11 1999-03-10 Эйсаи Ко., ЛТД Производные аминокислоты
CA2140553A1 (en) * 1993-06-11 1994-12-22 Hitoshi Oinuma Amino acid derivative

Also Published As

Publication number Publication date
DE60202602D1 (de) 2005-02-17
CN1501926A (zh) 2004-06-02
OA12502A (fr) 2006-05-29
CN1245404C (zh) 2006-03-15
HU229612B1 (en) 2014-03-28
BG108203A (bg) 2004-12-30
AU2002304804B2 (en) 2007-05-10
EP1381605B1 (en) 2005-01-12
SK12552003A3 (sk) 2004-03-02
PT1381605E (pt) 2005-03-31
RU2286346C2 (ru) 2006-10-27
BR0208889A (pt) 2004-06-29
SK287616B6 (sk) 2011-04-05
RU2003132875A (ru) 2005-03-20
SI1381605T1 (en) 2005-06-30
JP4392167B2 (ja) 2009-12-24
DE60202602T2 (de) 2006-03-23
EP1381605A1 (en) 2004-01-21
CA2443488A1 (en) 2002-10-24
CZ20032722A3 (cs) 2004-01-14
IL158289A0 (en) 2004-05-12
PL363034A1 (en) 2004-11-15
NO325655B1 (no) 2008-06-30
HK1061690A1 (en) 2004-09-30
EE200300500A (et) 2003-12-15
CA2443488C (en) 2011-05-31
PL209338B1 (pl) 2011-08-31
NZ528825A (en) 2005-04-29
BG66387B1 (bg) 2013-11-29
MXPA03008613A (es) 2003-12-08
WO2002083671A1 (en) 2002-10-24
MA26098A1 (fr) 2004-04-01
CZ299708B6 (cs) 2008-10-29
ATE286898T1 (de) 2005-01-15
HRP20030823A2 (en) 2005-08-31
HUP0303482A3 (en) 2012-12-28
ES2232752T3 (es) 2005-06-01
EE05272B1 (et) 2010-02-15
HUP0303482A2 (hu) 2004-01-28
HRP20030823B1 (en) 2011-10-31
NO20034412D0 (no) 2003-10-02
JP2004525966A (ja) 2004-08-26

Similar Documents

Publication Publication Date Title
TNSN03083A1 (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
YU77503A (sh) Derivati pirazola za tretiranje hiv
WO2004064730A3 (en) Compounds, compositions and methods
WO2005051325A3 (en) Carvedilol compositions methods of treatment and delivery
NO20006645L (no) Ny form av irbesartan, fremgangsmåte for å oppnå den nevnte form og farmasöytiske preparater inneholdende den samme
WO2003082857A3 (en) Lansoprazole polymorphs and processes for preparation thereof
DK1456212T3 (da) 6-aminomorphinanderivater, fremgangsmåder til fremstilling heraf og disses anvendelse
WO2002065834A3 (en) Novel formulations of carvedilol
NO20065075L (no) Ikke-nukleosidbaserte revers-transkriptase-inhibitorer.
WO2004012663A3 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
WO2003059258A3 (en) Compositions and methods for treating heart failure
DE60310767D1 (de) PYRAZOL-3,4-d-PYRIMIDINDERIVATE UND IHRE VERWENDUNG BEI DER BEHANDLUNG VON H.PYLORI-INFEKTIONEN
AP1766A (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
YU61103A (sh) Postupci za produkciju supstituisanih 2-(2-piridilmetil) sulfinil-1h-benzimidazola
WO2004032908A3 (en) Method of inhibiting angiogenesis
WO2003059265A3 (en) Compositions and methods for treating heart failure
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4
NO20034412D0 (no) Merkaptoacetylamidderivater, fremgangsmåte for deres fremstilling og deresanvendelse
WO2003028645A3 (en) Novel compositions of carvedilol
NO20054346L (no) Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander
NO20062022L (no) 1-(kinolinamino)- og 1-(isokinolinamino)-substituerte pentan-2-oler, fremgangsmate for fremstilling av disse og anvendelse av den som antiinflammatoriske midler
DK1387841T3 (da) Hidtil ukendt azol- eller triazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som fungicider
WO2003097593A3 (en) Protease inhibitors
AU2002326391A1 (en) Carvedilol polymorph
WO2002006190A3 (en) Crystalline and salt forms of an hiv protease inhibitor

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees